Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Consolidated Net Income: 2023-2025

Historic Consolidated Net Income for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to -$19.7 million.

  • Day One Biopharmaceuticals' Consolidated Net Income fell 154.94% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.7 million, marking a year-over-year increase of 21.59%. This contributed to the annual value of -$204.7 million for FY2024, which is 8.38% down from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Consolidated Net Income stood at -$19.7 million for Q3 2025, which was up 35.02% from -$30.3 million recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Consolidated Net Income registered a high of $35.8 million during Q3 2024, and its lowest value of -$112.4 million during Q2 2024.
  • Its 3-year average for Consolidated Net Income is -$43.4 million, with a median of -$44.3 million in 2023.
  • Data for Day One Biopharmaceuticals' Consolidated Net Income shows a peak YoY increase of 177.66% (in 2024) and a maximum YoY decrease of 165.16% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Day One Biopharmaceuticals' Consolidated Net Income stood at -$54.5 million in 2023, then fell by 20.61% to -$65.7 million in 2024, then tumbled by 154.94% to -$19.7 million in 2025.
  • Its Consolidated Net Income stands at -$19.7 million for Q3 2025, versus -$30.3 million for Q2 2025 and -$36.0 million for Q1 2025.